Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Authors
Keywords
-
Journal
NATURE IMMUNOLOGY
Volume 23, Issue 2, Pages 210-216
Publisher
Springer Science and Business Media LLC
Online
2022-01-14
DOI
10.1038/s41590-021-01113-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
- (2021) Sheila K. Patel et al. EUROPEAN RESPIRATORY JOURNAL
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Long-term follow-up of recovered patients with COVID-19
- (2021) Monica Cortinovis et al. LANCET
- Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection
- (2021) David R Darley et al. MEDICAL JOURNAL OF AUSTRALIA
- Attributes and predictors of long COVID
- (2021) Carole H. Sudre et al. NATURE MEDICINE
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- (2021) Sandra Lopez-Leon et al. Scientific Reports
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients
- (2020) Francisco Alejandro Lagunas‐Rangel et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury
- (2020) Zhongfang Wang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Post‐discharge symptoms and rehabilitation needs in survivors of COVID‐19 infection: a cross‐sectional evaluation
- (2020) Stephen J Halpin et al. JOURNAL OF MEDICAL VIROLOGY
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
- (2020) Jack Major et al. SCIENCE
- Type III interferons disrupt the lung epithelial barrier upon viral recognition
- (2020) Achille Broggi et al. SCIENCE
- Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020
- (2020) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Immune response in SARS-CoV-2 infection: the role of interferons type I and type III
- (2020) Caciane Portela Sousa et al. Brazilian Journal of Infectious Diseases
- Elevated plasma sTIM-3 levels in patients with severe COVID-19
- (2020) Thor Ueland et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype
- (2020) Jennifer R. Habel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
- (2020) Enrico Brunetta et al. NATURE IMMUNOLOGY
- Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia
- (2020) Michaela Gregorova et al. eLife
- Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite Controllers
- (2019) Chansavath Phetsouphanh et al. Frontiers in Immunology
- Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway
- (2016) Aoife Kelly et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Relationships of Elevated Systemic Pentraxin-3 Levels With High-Risk Coronary Plaque Components and Impaired Myocardial Perfusion After Percutaneous Coronary Intervention in Patients With ST-Elevation Acute Myocardial Infarction
- (2013) Shigeki Kimura et al. CIRCULATION JOURNAL
- Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors
- (2009) Marco Ho-Bun Lam ARCHIVES OF INTERNAL MEDICINE
- Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
- (2009) Giuseppe Danilo Norata et al. CIRCULATION
- Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
- (2008) Rebecca A. Lew et al. EXPERIMENTAL PHYSIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started